- Understanding the debate over PBMs🔍
- 5 Things To Know About Pharmacy Benefit Managers🔍
- Consequences of the FTC's biased attack on PBMs🔍
- The ABCs of PBMs🔍
- A brief look at current debates about pharmacy benefit managers🔍
- Healthcare Private Equity Transactions Under Scrutiny🔍
- Pharmacy Benefit Managers Scrutinized For Role In Drug Price ...🔍
- PBMs Archives < PBGH🔍
PBMs Face Increased Scrutiny
Understanding the debate over PBMs - Mercer.com
... increased PBM scrutiny? As we've discussed, under traditional pricing arrangements PBMs make a portion of their revenue through spread ...
5 Things To Know About Pharmacy Benefit Managers
Spread pricing, when PBMs receive a higher payment from insurers for a drug than the amount the PBMs pay to retail pharmacies for the drug, ...
2024 - FTC and Congress take action against PBMs for price gouging
Additionally, PBMs are facing increased scrutiny from Congress. The ... The proposed rule would alleviate barriers that patients face when ...
Consequences of the FTC's biased attack on PBMs | Evernorth
... higher premiums that Americans could face as a result. Their ... The Wall Street Journal. The FTC's Anti-PBM Suit Could Mean Higher Health ...
The ABCs of PBMs - NCBI Bookshelf
What challenges would the government face acting as a purchaser contracting with a PBM? ... Independent pharmacies contracting with PBMs have raised a number of ...
A brief look at current debates about pharmacy benefit managers
(MLR requirements compel insurers to spend a minimum share of premium revenue on claims or face some type of penalty; they apply to individual ...
Healthcare Private Equity Transactions Under Scrutiny: Midyear ...
Healthcare private equity transactions are under increasing scrutiny ... face substantial headwinds during next year's legislative session.
STAT Pbms - News and Analysis on Pharmacy Benefit Managers
Pharmacy Benefit Managers (PBM) are third-party administrators of prescription drug programs for health plans. They are under increasing government scrutiny.
Pharmacy Benefit Managers Scrutinized For Role In Drug Price ...
So drug makers increase drug prices and PBMs push the higher-rebate drugs over cheaper ones with a smaller rebate, thereby raising costs for ...
PBMs Archives < PBGH - Purchaser Business Group on Health
... scrutiny of PBM costs, fees and client representations. Success in ... PBMs to the exact standard that employers face. Without requiring PBMs to ...
LUGPA Policy Overview - Pharmacy Benefit Manager Reform in 2024
... PBMs lead to higher ... Although the FTC stops short of recommending breaking up PBMs, it calls for further scrutiny and potential regulation of certain business ...
PBMs battle bipartisan scrutiny as lawmakers eye industry reform
Tuesday's House committee report adds fuel to the fire, slamming the industry for steering patients to pharmacies the PBM owns and favoring more ...
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023 ...
... face competition from generic equivalents. ... PBM compensation models continue to evolve, due to increased scrutiny by payers, regulators, and ...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The three largest pharmacy benefit managers, or PBMs, act as middlemen overseeing prescriptions for more than 200 million Americans.
Pharmacy benefit managers or PBMs, the mysterious middlemen of ...
Why PBMs are under scrutiny from lawmakers. The trouble starts here ... “Over time, questions have been raised whether PBMs are ...
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ...
The FTC claims that these PBMs are manipulating the market by steering patients toward more expensive drugs, driven by higher rebates from manufacturers.
PBM Policy and Reform to Drive Pharmacy Transparency in 2024
The increased scrutiny of PBMs has led to major PBM reform efforts. Our blog dives into some of the key federal and state PBM initiatives.
PBMs hold 'enormous power' over drug prices: FTC
FTC investigation reveals PBM favoritism and market control, impacting medication access and affordability. Report calls for scrutiny of PBM ...
Lawmakers scrutinize 'black box of state PBM spending'
A review of five years of data from the state's major pharmacy benefit managers cataloged more than 63 million claims and nearly $6.7 billion paid to the ...
PBMs ramp up lobbying efforts amid growing public scrutiny
... rising drug costs comes under intense public scrutiny, according to a Reuters report. With companies such as CVS Health (NYSE:CVS), Cigna ...